Savaria Corporation (SIS) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. My name is Sarah and I will be your conference operator today. At this time, I would like to welcome everyone to Savaria Corporation's Q2 2025 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. To ask a question during the session, you will need to press star one and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one and one again. This call may contain forward looking statements, which are subject to the disclosure statement contained in Savaria's most recent press release, issued on the 6th of August 2025 with respect to its Q2 2025 results. Thank you, Mr. Barassa. You may begin your conference. Thanks, Sarah, and good morning, everyone. So today, I will start with a small recap of our Q2 results, then Steve will update us on financial and GP on Savaria 1, and then we'll follow up with a Q&A session. First, I'm very proud of our Q2 results as we have reached an important milestone of Savaria 1 with margins over 20%. We have achieved 20.6%. So congratulations to all Savaria employees and thank you for your dedication in this Savaria 1 program. Results show that the transformation is stable with a six good quarter in a row in an environment of uncertainty where all our products remain UMSCA compliant, meaning that there's no duty applicable on our finished products. So some of the key highlights fantastic performance of .6% for the entire business with accessibility at .9% combination of Europe and North America and patient care at 20.9%, which is mostly due to some improvement in Savaria 1 program, which GP will talk a bit later. With those results, we deci...